First Time Loading...

Axonics Inc
NASDAQ:AXNX

Watchlist Manager
Axonics Inc Logo
Axonics Inc
NASDAQ:AXNX
Watchlist
Price: 67.43 USD 0.04% Market Closed
Updated: May 13, 2024
Section:
 

Wall Street
Price Targets

AXNX Price Targets Summary
Axonics Inc

Wall Street analysts forecast AXNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXNX is 73.16 USD with a low forecast of 71.71 USD and a high forecast of 78.75 USD.

AXNX Lowest Forecast
Wall Street Target
71.71 USD
6% Upside
AXNX Average Forecast
Wall Street Target
73.16 USD
9% Upside
AXNX Highest Forecast
Wall Street Target
78.75 USD
17% Upside
Lowest
Price Target
71.71 USD
6% Upside
Average
Price Target
73.16 USD
9% Upside
Highest
Price Target
78.75 USD
17% Upside
Axonics Inc Competitors:
Price Targets
688271
Shanghai United Imaging Healthcare Co Ltd
18% Upside
2160
Microport Cardioflow Medtech Corp
113% Upside
SYK
Stryker Corp
17% Upside
GMED
Globus Medical Inc
3% Downside
688271
Shanghai United Imaging Healthcare Co Ltd
18% Upside
2160
Microport Cardioflow Medtech Corp
113% Upside
SYK
Stryker Corp
17% Upside
GMED
Globus Medical Inc
3% Downside
J
287410
Jeisys Medical Inc
36% Upside
LNSR
LENSAR Inc
116% Upside
LIFE
Lifecare AS
74% Upside
145720
Dentium Co Ltd
41% Upside

Revenue
Forecast

Revenue Estimate
Axonics Inc

For the last 6 years the compound annual growth rate for Axonics Inc's revenue is 293%. The projected CAGR for the next 3 years is 20%.

293%
Past Growth
20%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Axonics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Axonics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
What are analyst estimates?

See Also

Summary
AXNX intrinsic value, competitors valuation, and company profile.
DCF Valuation
AXNX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AXNX stock valuation using valuation multiples.
Wall Street Estimates
AXNX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AXNX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXNX's stock price target?
Price Target
73.16 USD

According to Wall Street analysts, the average 1-year price target for AXNX is 73.16 USD with a low forecast of 71.71 USD and a high forecast of 78.75 USD.

What is Axonics Inc's Revenue forecast?
Projected CAGR
20%

For the last 6 years the compound annual growth rate for Axonics Inc's revenue is 293%. The projected CAGR for the next 3 years is 20%.

ALPHA SPREAD
Join more than 136,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.